348 results
Post-bypass PCI: challenges and solutions
24 May 2019 – From EuroPCR 2019
Consult this session to learn all about the challenges and solutions regarding post-bypass PCI, with compelling clinical cases involving complex anatomies and innovative ways to cope with them.
Innovations in imaging and physiology
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about various studies and trials regarding innovations in imaging and physiology, such as the TrackCath system, the photoacoustic imaging of lipids in coronary atherosclerosis, and more!
Clinical value of DEB for coronary intervention
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the clinical value of drug-eluting baloons thanks to various studies and trials: PREVAIL, ELEGANT, and more!
High-bleeding risk PCI patients enrolled in ongoing clinical trials
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about high-bleeding risk PCI patients: how to identify them, how to successfully adapt PCI technique and how to select the optimal antiplatelet treatment post-PCI according to the patient's bleeding and thrombotic risks.
Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions
23 May 2019 – From EuroPCR 2019
Consult this session to learn about the updated perspective on the bleeding definition in interventional cardiology, and antithrombotic treatment regimens in atrial fibrillation patients undergoing PCI or TAVI.
What every interventional cardiologist should know about new cardiovascular drugs
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the impact of new cardiovascular drugs in patients with coronary artery disease, diabetes and other high-risk conditions, such as PCSK9 and SGLT-2 inhibitors, GLP1 agonists, and more!
Clinical use of intracoronary imaging - EAPCI expert consensus
Tom Johnson talks to Giulio Guagliumi about the EAPCI expert consensus document on intracoronary imaging that he presented at EuroPCR 2019. He explains that the document “acknowledges difficulties we as an interventional community have in understanding how best to apply this exciting technology to ensure the...
All you need to know about physiological assessment of coronary artery disease
Despite guidelines that recommend the use of physiological assessment in coronary artery disease, it is only used in less than 10% of cases. Join Emanuele Barbato and Carlos Collet as they look at some of the reasons behind this low rate of implementation. They describe a...
What every interventional cardiologist should know about new cardiovascular drugs
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about the major impact of several new cardiovascular drugs in patients with coronary artery disease, diabetes and other high-risk conditions, such as PCSK9, DAPT, and more!
The evolving role of physiology and imaging - Tools to support your efforts: diagnostic to post-PCI
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about post-PCI physiology assessments, microcatheter-based post-stent FFR procedures and post-PCI intravascular imaging in high-definition.
